Allianz Life Insurance Co of North America acquired a new position in shares of Humana Inc (NYSE:HUM) in the first quarter, HoldingsChannel reports. The firm acquired 890 shares of the insurance provider’s stock, valued at approximately $239,000.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. CCM Investment Advisers LLC grew its stake in Humana by 0.5% during the 1st quarter. CCM Investment Advisers LLC now owns 39,289 shares of the insurance provider’s stock worth $10,562,000 after buying an additional 210 shares during the last quarter. AMF Pensionsforsakring AB grew its stake in Humana by 1.1% during the 1st quarter. AMF Pensionsforsakring AB now owns 27,680 shares of the insurance provider’s stock worth $7,441,000 after buying an additional 290 shares during the last quarter. YorkBridge Wealth Partners LLC grew its stake in Humana by 99.0% during the 4th quarter. YorkBridge Wealth Partners LLC now owns 597 shares of the insurance provider’s stock worth $159,000 after buying an additional 297 shares during the last quarter. Brinker Capital Inc. grew its stake in Humana by 16.7% during the 1st quarter. Brinker Capital Inc. now owns 2,377 shares of the insurance provider’s stock worth $640,000 after buying an additional 341 shares during the last quarter. Finally, Stratos Wealth Partners LTD. grew its stake in Humana by 448.7% during the 1st quarter. Stratos Wealth Partners LTD. now owns 417 shares of the insurance provider’s stock worth $112,000 after buying an additional 341 shares during the last quarter. Hedge funds and other institutional investors own 93.33% of the company’s stock.
Shares of Humana opened at $300.25 on Thursday, Marketbeat.com reports. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $42.01 billion, a PE ratio of 25.64, a PEG ratio of 1.58 and a beta of 0.92. Humana Inc has a fifty-two week low of $229.84 and a fifty-two week high of $309.18.
Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, May 2nd. The insurance provider reported $3.36 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.21 by $0.15. The business had revenue of $14.28 billion during the quarter, compared to analyst estimates of $14.22 billion. Humana had a return on equity of 16.74% and a net margin of 3.36%. During the same quarter in the prior year, the firm posted $2.75 earnings per share. equities analysts anticipate that Humana Inc will post 13.99 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 27th. Stockholders of record on Friday, June 29th will be issued a $0.50 dividend. The ex-dividend date is Thursday, June 28th. This represents a $2.00 annualized dividend and a dividend yield of 0.67%. Humana’s dividend payout ratio (DPR) is 17.08%.
A number of brokerages recently commented on HUM. Zacks Investment Research downgraded Humana from a “buy” rating to a “hold” rating in a research note on Friday, May 25th. ValuEngine downgraded Humana from a “buy” rating to a “hold” rating in a research note on Saturday, June 2nd. Oppenheimer upped their price objective on Humana from $305.00 to $311.00 and gave the stock an “outperform” rating in a research note on Thursday, May 3rd. Piper Jaffray Companies reiterated a “buy” rating and set a $313.00 price target on shares of Humana in a research report on Wednesday, April 4th. Finally, Citigroup reiterated a “buy” rating and set a $340.00 price target (up previously from $280.00) on shares of Humana in a research report on Friday, June 1st. Eight equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $283.78.
In other news, SVP Cynthia H. Zipperle sold 1,000 shares of the company’s stock in a transaction on Wednesday, June 13th. The stock was sold at an average price of $306.01, for a total value of $306,010.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Elizabeth D. Bierbower sold 6,036 shares of the company’s stock in a transaction on Monday, June 11th. The shares were sold at an average price of $300.91, for a total value of $1,816,292.76. Following the completion of the sale, the insider now owns 21,683 shares of the company’s stock, valued at approximately $6,524,631.53. The disclosure for this sale can be found here. In the last 90 days, insiders sold 112,541 shares of company stock valued at $33,453,624. Insiders own 0.60% of the company’s stock.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.